The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a nonpartisan foundation focused on improving the health of communities and entire populations.
February 21, 2019
View from Here
Sustainable Health Care Costs
Christopher F. Koller
Apr 13, 2022
Sep 14, 2021
Aug 5, 2021
Back to The View from Here
Health care costs comprise an expansive and poorly mapped forest. There are plenty of fearful features to the wilderness, including rising pharmaceutical costs, consolidating providers, multiplying administrators, aging populations, chronic diseases, and poor health behaviors. Different regions—Medicare, Medicaid, and private health insurance—evoke different and conflicting concerns and fears.
All these features can and should attract the attention of researchers and policymakers seeking a more cost-effective health care system. But excessive attention to any one component will blind us to the bigger view. Some recent contributions to the health services research literature help us see the forest through the trees a bit better and make the case that the private health insurance part of the jungle is the most dangerous. Fortunately, some states are already finding their path through it.
First, Anderson and colleagues in a January 2019 Health Affairs article argue persuasively that the US continues to pay more per capita for health care than other countries because of higher provider prices, not excessive utilization. Because Medicare and Medicaid set their prices, they argue that the area for policy focus should be what private health insurance pays providers.
There is also convincing evidence that per capita cost trends are rising faster for private health insurance than for public payers. Recently in a February 2019 Health Affairs article, Cooper and colleagues compare per capita trends for commercial health insurance and Medicare between 2007 and 2014 by health care market (Hospital Referral Region). They found higher rates of increase and more variation by market for commercial health insurance than for Medicare.
Cost concerns for Medicare and Medicaid remain real—just ask state and federal budget officials trying to make their numbers work. But if Anderson and Cooper and their colleagues are correct, in the future these costs will be driven by increases in the number of people enrolled, not by per capita trends.
So if provider prices in commercial health insurance are driving per capita cost levels and increases, which providers should we be focusing on? Cooper and other researchers have a second analysis in Health Affairs, and the answer is not surprising. “In the period 2007–14 hospital prices grew substantially faster than physician prices,” they state. “For inpatient care, hospital prices grew 42%, while physician prices grew 18%. Similarly, for hospital-based outpatient care, hospital prices grew 25%, while physician prices grew 6%.”
A narrative starts to emerge here—a view of the forest. Providers—especially those with negotiating leverage—take advantage of the confidential negotiating process with commercial insurers to obtain higher prices for their services. Insurers, seeking to keep providers in their network, concede to higher levels and higher rates of price increases than Medicare or Medicaid and pass those costs on to employers. Rising pharmaceutical expenses accelerate these increases. Employers, seeking to manage their expenses, adopt product designs that push more costs onto employees. For even these reduced benefits, employees forfeit wage gains and either reduce their utilization of health care services, reduce other expenses to pay for health care, or go into medical debt.
When confronted with this behavior, institutional providers point to alleged underpayments by Medicare and Medicaid—the “cost shift” argument. This ignores the fact that commercial hospital rates as a percentage of Medicare vary both across the country and in the same market. Ongoing studies by the Division of Health Care Financing and Policy in Colorado indicate that excess commercial payments in that state do not fund any public payer shortfalls, but instead support higher administrative costs, higher hospital margins, practice acquisition and building costs. Repeated analyses by independent health economists have come to the same conclusion.
In private negotiations, leverage matters, and costs rise to the level of revenue available.
It does not have to be that way. Finding a path out of this jungle of provider pricing for commercial health insurance, however, will fall to the states and not the federal government. Analysis from the Health Care Cost Institute shows that metropolitan Baltimore in Maryland, the only state with all-payer hospital rate setting (a practice given up by other states in the 1980s in the wake of Ronald Reagan’s assertion that government was the problem, not the solution), enjoys lower overall provider prices for commercial insurance for a similar bundle of services than any other market in the country. (See Figure One).
Figure One: Average Provider Prices for a Similar Bundle of Services
Source: Health Care Cost Institute Healthy Marketplace Index https://www.healthcostinstitute.org/research/hmi
Not surprisingly, a study of total costs of private health insurance in six markets by the Network for Regional Health Care Improvement showed Baltimore to be the cheapest among them. Analysis by federal officials last year indicates these low commercial rates are not subsidized by higher Medicare and Medicaid costs. As for the effects on quality and innovation, Maryland’s all-payer rate-setting structure supports an internationally known academic medical institution in Johns Hopkins and hospitals that are systematically weaning themselves from fee-for-service payments. Vermont’s statewide all-payer accountable care organization (OneCare), when fully implemented, is envisioned to be a northern version of Maryland’s effort.
When I was Health Insurance Commissioner in Rhode Island we documented the same provider price dynamic noted by Cooper—but all-payer provider rate setting was a bridge too far, and we were impatient. States can follow Rhode Island’s lead and use insurer rate regulation to limit provider rate increases and bend the commercial insurance trend (Figure Two)—giving the savings back to employers in lower increases in premiums, to employees in lower cost-sharing, and to the delivery system in primary care investments.
Figure Two: Commercial Insurance Payments (per person per quarter) in Rhode Island vs a Matched Comparison
Source: Baum et al. Health Affairs, February 2019
And if full-on rate regulation is not acceptable policy, how about a little daylight? Insurers and providers alike zealously guard the secrecy of their rate negotiations but the proliferation of all-payer claims databases make their outcomes publicly available if leaders are willing to analyze and communicate them and deal with the howls of outrage from proponents of the status quo. The Attorney General in Massachusetts and the Health Insurance Commissioner in Rhode Island informed and activated their states’ employers regarding the excess prices they were paying providers with good public reporting that named names. Now officials in Colorado, Montana, and Delaware are doing the same.
We pay more for our health care in the US because we pay our providers more—especially in commercial insurance and to our hospitals and hospital-affiliated providers. It is logically inconsistent and socially costly that half of the financing for our health care system relies on transparent, publicly administered pricing, while the other half is shrouded in secrecy. If employers, employees, and public officials really think their money could be better spent elsewhere, they must be willing to illuminate the “jungle” of provider pricing for commercial insurance and then map the forest for a path out.
Get the Latest from the Milbank Memorial Fund
An endowed operating foundation that engages in nonpartisan analysis, collaboration, and communication, with an emphasis on state health policy.